Some also include additional mechanismsfor example, Mounjaro and Zepbound combine GLP-1 with GIP (glucose-dependent insulinotropic polypeptide) for added effect
We keep pricing straightforward and competitive
Low protein intake during GLP-1 therapy leads to excessive muscle loss relative to fat loss
Since then, more than ten types of GLP-1 receptor agonists have received FDA approval and been brought to market, and with each new version, their effectiveness has increased
TD: Tardive Dyskinesia for total (+) active metabolites for tetrabenazine & deutetrabenazine Schneider et al (2021) Adapted from Diana (2007), Schneider et al (2021) & Cheung & Parmar (2022) Notes on Reserpine & Synaptic vesicles:
Semaglutide reduces appetite by slowing gastric emptying and increasing feelings of fullness, which can inadvertently lower your total nutrient intake